These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 31170287)

  • 1. Inoculum effect of β-lactam antibiotics.
    Lenhard JR; Bulman ZP
    J Antimicrob Chemother; 2019 Oct; 74(10):2825-2843. PubMed ID: 31170287
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Mossman AK; Svishchuk J; Waddell BJM; Izydorczyk CS; Buckley PT; Hilliard JJ; Al-Ghalith G; Zheng L; Lynch AS; Mody CH; Lisboa LF; Gregson DB; Parkins MD
    Ann Am Thorac Soc; 2022 Aug; 19(8):1285-1293. PubMed ID: 35213810
    [No Abstract]   [Full Text] [Related]  

  • 3. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inoculum effect of methicillin-susceptible Staphylococcus aureus against broad-spectrum beta-lactam antibiotics.
    Song KH; Jung SI; Lee S; Park S; Kim ES; Park KH; Park WB; Choe PG; Kim YK; Kwak YG; Kim YS; Jang HC; Kiem S; Kim HI; Kim HB;
    Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):67-74. PubMed ID: 30269181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
    Hsueh PR; Chen WH; Luh KT
    Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase.
    Kang CI; Pai H; Kim SH; Kim HB; Kim EC; Oh MD; Choe KW
    J Antimicrob Chemother; 2004 Dec; 54(6):1130-3. PubMed ID: 15486080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of gram-negative β-lactamase producing pathogens in the clinical lab.
    Thomson KS
    Curr Pharm Des; 2013; 19(2):250-6. PubMed ID: 22894616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral carbapenems.
    Shah PM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():175-80. PubMed ID: 18154543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M; Browne FA; Jacobs MR; Appelbaum PC
    Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
    Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW
    Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story.
    Richmond MH
    Rev Infect Dis; 1979; 1(1):30-8. PubMed ID: 400938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC; Hsueh PR
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation.
    Chapman SW; Steigbigel RT
    J Infect Dis; 1983 Jun; 147(6):1078-89. PubMed ID: 6602190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ceftobiprole activity against a variety of gram-negative pathogens, including Escherichia coli, Haemophilus influenzae (β-lactamase positive and β-lactamase negative), and Klebsiella pneumoniae, in a rabbit meningitis model.
    Stucki A; Cottagnoud M; Acosta F; Egerman U; Läuffer J; Cottagnoud P
    Antimicrob Agents Chemother; 2012 Feb; 56(2):921-5. PubMed ID: 22064544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.
    Li J; Echevarria KL; Traugott KA
    Pharmacotherapy; 2017 Mar; 37(3):346-360. PubMed ID: 28035690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid optical determination of β-lactamase and antibiotic activity.
    Khan S; Sallum UW; Zheng X; Nau GJ; Hasan T
    BMC Microbiol; 2014 Apr; 14():84. PubMed ID: 24708478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of a new penem FCE 22101.
    Hoban DJ
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():53-7. PubMed ID: 2786518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.